Medical Aspects of Chemical Warfare (2008) - The Black Vault

More documents

Recommendations

Info

Medical Management of Chemical Casualties Field Training Site, Aberdeen Proving Ground, Edgewood Arsenal,Edgewood, Maryland. US Army healthcare professionals training for medical management of chemicalcasualties. The healthcare professionals are equipped with the latest protective equipment: the Joint ServiceLightweight Integrated Suit Technology and the M50 protective mask.Photograph by Stephanie R. Froberg, US Army Medical Research Institute of Chemical Defense, 2007.vi
Page 3 and 4: The Coat of Arms1818Medical Departm
Page 5: Textbooks of Military MedicinePubli
Page 9 and 10: Editorial Staff:Joan ReddingSenior
Page 11 and 12: 14. Field Management of Chemical Ca
Page 13 and 14: RICHARD K. GORDON, PhDChief, Depart
Page 15 and 16: PATRICK WILLIAMS, MSResearch Biolog
Page 17 and 18: xvi
Page 19 and 20: xviii
Page 22 and 23: AcknowledgmentsBoard Subject Matter
Page 24 and 25: Introduction to the Chemical Threat
Page 32 and 33: History of Chemical WarfareChapter
Page 34 and 35: History of Chemical Warfareand 72 b
Page 36 and 37: History of Chemical WarfareFig. 2-2
Page 38 and 39: History of Chemical WarfareExhibit
Page 46 and 47: History of Chemical WarfareTable 2-
Page 48 and 49: History of Chemical Warfarehave bee
Page 54 and 55: History of Chemical WarfareabFig. 2
Page 56 and 57:
History of Chemical WarfareFig. 2-2
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
History of Chemical WarfareTable 2-
Page 64 and 65:
History of Chemical WarfareTable 2-
Page 66 and 67:
History of Chemical WarfareNorth Af
Page 68 and 69:
History of Chemical Warfaregases, o
Page 70 and 71:
History of Chemical WarfareExhibit
Page 72 and 73:
History of Chemical Warfarecourse o
Page 74 and 75:
History of Chemical WarfareabSoviet
Page 76 and 77:
History of Chemical Warfarea chemic
Page 78 and 79:
History of Chemical Warfareof the C
Page 80 and 81:
History of Chemical Warfareassigned
Page 82 and 83:
History of Chemical WarfareDevelopm
Page 84 and 85:
History of Chemical Warfarethe Army
Page 86 and 87:
History of Chemical WarfareAfter Ir
Page 88 and 89:
History of Chemical Warfaresarin- a
Page 90 and 91:
History of Chemical Warfare5. Mauro
Page 92 and 93:
History of Chemical Warfare45. Coch
Page 94 and 95:
History of Chemical Warfare90. Nyl
Page 96 and 97:
History of Chemical Warfare134. US
Page 98 and 99:
History of Chemical Warfare183. Hai
Page 100 and 101:
History of the Medical Management o
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
History of the Chemical ThreatChapt
Page 140 and 141:
History of the Chemical ThreatFig.
Page 142 and 143:
History of the Chemical ThreatIn 19
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
History of the Chemical Threatbe ab
Page 150 and 151:
History of the Chemical Threatinter
Page 152 and 153:
History of the Chemical ThreatBruey
Page 154 and 155:
History of the Chemical Threatcapab
Page 156 and 157:
History of the Chemical Threat Fi
Page 158 and 159:
History of the Chemical Threatthey
Page 160 and 161:
History of the Chemical ThreatAmmun
Page 162 and 163:
History of the Chemical Threatratif
Page 164 and 165:
History of the Chemical Threatgate
Page 166 and 167:
History of the Chemical Threatdecon
Page 168 and 169:
History of the Chemical ThreatGerma
Page 170 and 171:
History of the Chemical Threat9. Sm
Page 172 and 173:
History of the Chemical Threat51. S
Page 174 and 175:
History of the Chemical Threat87. G
Page 176:
History of the Chemical Threat123.
Page 179 and 180:
Medical Aspects of Chemical Warfare
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 244 and 245:
Neuroprotection as a Treatment for
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Nerve Agent Bioscavenger: Developme
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
VesicantsChapter 8VESICANTSCharles
Page 284 and 285:
Vesicantscertain neoplasms. 5-8 In
Page 286 and 287:
Vesicantsmonograph by Jan L Willems
Page 288 and 289:
Vesicantsand other inhibitors of PA
Page 290 and 291:
Vesicantsmainly by the time needed
Page 292 and 293:
VesicantsabcdFig. 8-6. Transient hy
Page 294 and 295:
Vesicantstions with margination, di
Page 296 and 297:
Vesicantsdirectly by the alkylating
Page 298 and 299:
Vesicantsdropped into the eyes of r
Page 300 and 301:
Vesicantsdiagnosis. Friction, plant
Page 302 and 303:
Vesicantsinfusion rates and formula
Page 304 and 305:
Vesicantsactivity against a broad s
Page 306 and 307:
Vesicantsries because of the unique
Page 308 and 309:
Vesicantsdebridement, albeit more t
Page 310 and 311:
Vesicantsresurfacing, dermabrasion,
Page 312 and 313:
VesicantsabcFig. 8-14. (a) Bronchos
Page 314 and 315:
Vesicantstion without significant t
Page 316 and 317:
Vesicants• the inflammatory react
Page 318 and 319:
VesicantsClinical EffectsPhosgene o
Page 320 and 321:
Vesicants25. Aitken RS. Effects of
Page 322 and 323:
Vesicants64. Momeni A, Enshaeih S,
Page 324 and 325:
Vesicants101. Marshall EK Jr. Physi
Page 326 and 327:
Vesicants141. Barillo DJ, McManus A
Page 328 and 329:
Vesicants179. Eldad A, Weinberg A,
Page 330 and 331:
Vesicants219. Rheinwald JG, Green H
Page 332 and 333:
Vesicants260. Prandtl W, Sennewald
Page 334 and 335:
Long-Term Health Effects of Chemica
Page 336 and 337:
Page 338 and 339:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Toxic Inhalational Injury and Toxic
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
PROCESSToxic Inhalational Injury an
Page 380 and 381:
PROCESSToxic Inhalational Injury an
Page 382 and 383:
Page 384 and 385:
Page 386 and 387:
Page 388 and 389:
Page 390 and 391:
Page 392 and 393:
Page 394 and 395:
Cyanide PoisoningChapter 11CYANIDE
Page 396 and 397:
Cyanide Poisoningas “the cherry d
Page 398 and 399:
Cyanide PoisoningFig. 11-1. Likely
Page 400 and 401:
Cyanide PoisoningToxicityAlthough g
Page 402 and 403:
Cyanide PoisoningTable 11-2 continu
Page 404 and 405:
Cyanide PoisoningTABLE 11-3Endogeno
Page 406 and 407:
Cyanide Poisoningcyanide may cause
Page 408 and 409:
Cyanide PoisoningHCNCCOHbO 2MetHbHC
Page 410 and 411:
Cyanide Poisoningcyanide has been i
Page 412 and 413:
Cyanide Poisoningputed tomography s
Page 414 and 415:
Cyanide PoisoningDose (mg/kg)16.014
Page 416 and 417:
Cyanide PoisoningVoltage (mV)40200-
Page 418 and 419:
Cyanide PoisoningTable 11-5Antidote
Page 420 and 421:
Cyanide Poisoningbitol, and other B
Page 422 and 423:
Cyanide Poisoning23. Knight AP, Wal
Page 424 and 425:
Cyanide Poisoning64. Paulet G, Char
Page 426 and 427:
Cyanide Poisoning106. Goenechea S.
Page 428 and 429:
Cyanide Poisoning145. Mégarbane B,
Page 430 and 431:
Cyanide Poisoning187. Bucaretchi F,
Page 432 and 433:
Cyanide Poisoning226. Chen KK, Rose
Page 434 and 435:
Incapacitating AgentsChapter 12INCA
Page 436 and 437:
Incapacitating Agentsdrugged wine,
Page 438 and 439:
Incapacitating Agentstheir impact.
Page 440 and 441:
Incapacitating Agentsout a series o
Page 442 and 443:
Incapacitating Agentsthis chapter.D
Page 444 and 445:
Incapacitating Agents“Biotechnolo
Page 446 and 447:
Incapacitating Agentsconditions and
Page 448 and 449:
Incapacitating AgentsSeveral other
Page 450 and 451:
Incapacitating AgentsSafety of the
Page 452 and 453:
Incapacitating AgentsTABLE 12-1DIFF
Page 454 and 455:
Incapacitating AgentsNonLethal Weap
Page 456 and 457:
Incapacitating Agents7. Gaultier M,
Page 458 and 459:
Incapacitating Agents47. Buckman J.
Page 460 and 461:
Incapacitating Agents87. Chen Y, Da
Page 462 and 463:
Incapacitating Agents126. Sidell FR
Page 464 and 465:
Riot Control AgentsChapter 13Riot C
Page 466 and 467:
Riot Control AgentsPolice departmen
Page 468 and 469:
Riot Control AgentsTable 13-1CHARAC
Page 470 and 471:
Riot Control Agentsal 27 reported t
Page 472 and 473:
Riot Control Agentsoxygen from the
Page 474 and 475:
Riot Control Agentscaused the CS to
Page 476 and 477:
Riot Control Agentsnumerous factors
Page 478 and 479:
Riot Control Agentsexposure. In hum
Page 480 and 481:
Riot Control Agentsrespiration (RD
Page 482 and 483:
Riot Control AgentsTable 13-3 conti
Page 484 and 485:
Riot Control Agentsand increased li
Page 486 and 487:
Riot Control AgentsCN for years. In
Page 488 and 489:
Riot Control AgentsClinical Effects
Page 490 and 491:
Riot Control AgentsCR (Dibenz(b,f)(
Page 492 and 493:
Riot Control Agentsability and that
Page 494 and 495:
Riot Control AgentsNC); or Cool It!
Page 496 and 497:
Riot Control Agentswithout adequate
Page 498 and 499:
Riot Control Agents36. Thomas RJ, S
Page 500 and 501:
Riot Control Agents73. Olajos EJ, S
Page 502 and 503:
Riot Control Agents112. Centers for
Page 504 and 505:
Riot Control Agents153. Owens EJ, M
Page 506 and 507:
Riot Control Agents189. Carter, RH,
Page 508 and 509:
Field Management of Chemical Casual
Page 510 and 511:
Page 512 and 513:
Page 514 and 515:
Page 516 and 517:
Page 518 and 519:
Page 520 and 521:
Page 522 and 523:
Page 524 and 525:
Page 526 and 527:
Page 528 and 529:
Page 530 and 531:
Page 532:
Page 535 and 536:
Page 537 and 538:
Page 539 and 540:
Page 541 and 542:
Page 543 and 544:
Page 545 and 546:
Page 547 and 548:
Page 549 and 550:
Page 551 and 552:
Page 553 and 554:
Page 555 and 556:
Page 557 and 558:
Page 559 and 560:
Page 561 and 562:
Page 563 and 564:
Page 565 and 566:
Page 567 and 568:
Page 569 and 570:
Page 571 and 572:
Page 573 and 574:
Page 575 and 576:
Page 577 and 578:
Page 579 and 580:
Page 582 and 583:
Chemical Defense EquipmentChapter 1
Page 584 and 585:
Chemical Defense EquipmentINDIVIDUA
Page 586 and 587:
Chemical Defense EquipmentThe faceb
Page 588 and 589:
Chemical Defense Equipmentquantitat
Page 590 and 591:
Chemical Defense EquipmentabFig. 17
Page 592 and 593:
Chemical Defense Equipmentabjoint s
Page 594 and 595:
Chemical Defense EquipmentExhibit 1
Page 596 and 597:
Chemical Defense Equipmentworn for
Page 598 and 599:
Chemical Defense EquipmentPsycholog
Page 600 and 601:
Page 602 and 603:
Page 604 and 605:
Chemical Defense Equipmentgerous ch
Page 606 and 607:
Chemical Defense Equipmenttuses pre
Page 608 and 609:
Chemical Defense Equipmentcollectiv
Page 610 and 611:
Page 612 and 613:
Chemical Defense Equipmentdecontami
Page 614 and 615:
Chemical Defense Equipment22. Depar
Page 616 and 617:
Occupational Health and the Chemica
Page 618 and 619:
Page 620 and 621:
Page 622 and 623:
Page 624 and 625:
Page 626 and 627:
Page 628 and 629:
Page 630 and 631:
Page 632 and 633:
Page 634 and 635:
Page 636 and 637:
Toxins: Established and Emergent Th
Page 638 and 639:
Page 640 and 641:
Page 642 and 643:
Page 644 and 645:
Page 646 and 647:
Page 648 and 649:
Page 650 and 651:
Page 652 and 653:
Page 654 and 655:
Page 656 and 657:
Page 658 and 659:
Page 660 and 661:
Page 662 and 663:
Page 664 and 665:
Page 666 and 667:
Page 668 and 669:
Medical Chemical Defense Acquisitio
Page 670 and 671:
Page 672 and 673:
Page 674 and 675:
Page 676 and 677:
Page 678 and 679:
Medical Management of Chemical Toxi
Page 680 and 681:
Page 682 and 683:
Page 684 and 685:
Page 686 and 687:
Page 688 and 689:
Page 690 and 691:
Page 692 and 693:
Page 694 and 695:
Page 696 and 697:
Page 698 and 699:
Page 700 and 701:
Page 702 and 703:
Page 704 and 705:
Page 706 and 707:
Page 708 and 709:
Page 710 and 711:
Page 712 and 713:
Page 714 and 715:
Medical DiagnosticsChapter 22MEDICA
Page 716 and 717:
Medical Diagnosticsdifficult to int
Page 718 and 719:
Medical Diagnosticshalf-life rates
Page 720 and 721:
Medical DiagnosticsTable 22-1Analyt
Page 722 and 723:
Medical Diagnosticsplus the parent
Page 724 and 725:
Medical Diagnosticsas soman. Few me
Page 726 and 727:
Medical DiagnosticsHuman blood coll
Page 728 and 729:
Medical DiagnosticsTable 22-5Red Bl
Page 730 and 731:
Medical Diagnosticsrecently, a larg
Page 732 and 733:
Medical Diagnosticsof deuterated TD
Page 734 and 735:
Medical DiagnosticsTable 22-8Target
Page 736 and 737:
Medical DiagnosticsLC-MS-MS method
Page 738 and 739:
Medical DiagnosticsTable 22-9 conti
Page 740 and 741:
Medical Diagnosticsmonosulfoxide MS
Page 742 and 743:
Medical Diagnosticsisolation of the
Page 744 and 745:
Medical DiagnosticsabcOCH 2CH 2SCH
Page 746 and 747:
Medical DiagnosticsabcglobinSOCglob
Page 748 and 749:
Medical DiagnosticsExhibit 22-3 con
Page 750 and 751:
Medical DiagnosticsTable 22-12Publi
Page 752 and 753:
Medical DiagnosticsClHAsCCClClHaH 2
Page 754 and 755:
Medical Diagnosticsurine samples. T
Page 756 and 757:
Medical DiagnosticsTable 22-13 cont
Page 758 and 759:
Medical DiagnosticsThe estimated LC
Page 760 and 761:
Medical Diagnosticsstudy of chlorof
Page 762 and 763:
Medical DiagnosticsNOOCCOH(Figure 2
Page 764 and 765:
Medical DiagnosticsStorageUpon arri
Page 766 and 767:
Medical Diagnostics25. Noort D, Hul
Page 768 and 769:
Medical Diagnostics63. EQM Research
Page 770 and 771:
Medical Diagnostics99. Sandelowsky
Page 772 and 773:
Medical Diagnostics136. Izraeli S,
Page 774 and 775:
Medical Diagnostics181. Guastadiseg
Page 776 and 777:
Domestic PreparednessChapter 23Dome
Page 778 and 779:
Domestic Preparednessefforts led to
Page 780 and 781:
Domestic PreparednessaIncidentComma
Page 782 and 783:
Domestic PreparednessNIMS Framework
Page 784 and 785:
Domestic Preparednessmost likely be
Page 786 and 787:
Domestic Preparedness17 corpsmen. A
Page 788 and 789:
Domestic PreparednessNational Prepa
Page 790 and 791:
Domestic Preparednessdiation and re
Page 792 and 793:
Domestic Preparednesstreatment, and
Page 794 and 795:
Domestic Preparedness7. US Office o
Page 796:
Domestic Preparedness47. Federal Em
Page 799 and 800:
Page 802 and 803:
IndexIndexAAberdeen Biological Chem
Page 804 and 805:
Indexchlorine gas attack and, 66Aum
Page 806 and 807:
Indexbioscavenger use, 245, 706desc
Page 808 and 809:
Indexpsychological effect of, 2, 19
Page 810 and 811:
IndexZyklon B development, 15Cyanid
Page 812 and 813:
Indexpackaging specimens, 740phosge
Page 814 and 815:
Indexassignment of specific emergen
Page 816 and 817:
Indexsoman-induced seizure-related
Page 818 and 819:
Indexlegal barriers to acceptance a
Page 820 and 821:
IndexKKargin, Col. V.A.capture of s
Page 822 and 823:
Indexdescription and uses, 566M40A1
Page 824 and 825:
Indextive liner systemdescription a
Page 826 and 827:
Indexeffects of exposure to nerve a
Page 828 and 829:
IndexOccupational Safety and Health
Page 830 and 831:
IndexPersian Gulf War. See also Ope
Page 832 and 833:
Index704red blood cell and acetylch
Page 834 and 835:
IndexShaw, F.H.organophosphate inse
Page 836 and 837:
Indexseizure-related brain damage a
Page 838 and 839:
IndexTreatment of nerve agent expos
Page 840 and 841:
Indexevacuation hospitals, 94-95eva
Page 842 and 843:
IndexT-shell development, 14VR nerv
Page 844 and 845:
Dedicated to the Memory ofBrennie E
show all

Medical Aspects of Chemical Warfare (2008) - The Black Vault

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?